Integra LifeSciences Holdings Corporation (IART) vs Janux Therapeutics, Inc. (JANX)
A side-by-side comparison of Integra LifeSciences Holdings Corporation and Janux Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IART
Integra LifeSciences Holdings Corporation
$13.30HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
JANX
Janux Therapeutics, Inc.
$17.20HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — IART vs JANX
growth of $100 · dividends reinvested · last 5yIART -80.7% (-28.0%/yr)JANX -34.2% (-8.0%/yr)JANX compounded faster over this window
IART JANX
IART vs JANX: by the numbers
- •JANX is the larger company ($1.05B vs $1.03B market cap).
- •Both run net losses; IART's is the smaller (-0.44% vs -321.81% net margin).
- •JANX grew revenue faster over the past five years (105.89% vs 1.77% CAGR).
Metrics side by side
Valuation
| Metric | IART | JANX |
|---|---|---|
| Forward P/E | 5.45 | N/A |
| P/S ratio | 0.63 | 32.90 |
| P/B ratio | 0.98 | 1.13 |
| EV / EBITDA | 3.54 | N/A |
Profitability
| Metric | IART | JANX |
|---|---|---|
| Gross margin | 53.74% | 79.71% |
| Operating margin | 4.18% | -1576.67% |
| Net margin | -0.44% | -321.81% |
| ROE | -0.69% | -11.06% |
| ROIC | 20.01% | -15.15% |
Growth (annualized)
| Metric | IART | JANX |
|---|---|---|
| Revenue CAGR (5Y) | 1.77% | 105.89% |
| Total return CAGR (5Y) | -28.16% | -6.45% |
Frequently asked
- Which has grown faster, IART or JANX?
- Over the past five years, JANX grew revenue faster — IART at a 1.77% CAGR versus JANX at 105.89%.
- How have IART and JANX total returns compared?
- Over the past 5 years, IART delivered -28.16% and JANX delivered -6.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Integra LifeSciences ROEJanux Therapeutics ROEIntegra LifeSciences operating marginJanux Therapeutics operating marginIntegra LifeSciences revenue growthJanux Therapeutics revenue growthIntegra LifeSciences free cash flowJanux Therapeutics free cash flow
Integra LifeSciences & Janux Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.